Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1008

Alias

科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab

Molecular Name

Ixekizumab

Size

￥500/100ug, ￥3200/1mg, ￥6800/5mg, 定制报价/10mg以上

CAS Number

1143503-69-8

Isotype

IgG4 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

146.16 kDa

Applications

WB, IP, IF, FuncS, FC, Neut, ELISA

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6492H10012N1728O2028S46

Target

IL17A [Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用，不得用于人体或治疗用途。

靶点背景信息

实验方案&FAQ